Bristol-Celgene Merger Leaps FTC Clearance; Deal Set To Close Wednesday [Investor's Business Daily]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Investors Business Daily
Related news 11/14/2019 Pfizer stock has tumbled, below other pharmaceutical stocks. Recent news has been upbeat with a drug approval and acquisitions. But... Merck Stock Is On An Upswing In 2019 — Should You Buy This Pharma Stock? BMY Stock Plus Celgene Will Be A Top 5 Pharma — But Should You Buy It? Franco Nevada Joins 3 Separate IBD Stock Watchlists; Is It On Yours? Can This Biotech Improve On Bristol-Myers' Blockbuster Cancer Drug? The Art Of Portfolio Management: Fewer Growth Stocks Are The Best Path To A Big Return How Celgene Added A New Drug To Its Wheelhouse A Month Early Why You Should Keep An Eye On These 4 Leading Health Care Stocks CBRE, CareTrust REIT, 15 Other Stocks Join IBD's Watchlists Bristol-Myers Squibb ( BMY ) and Celgene ( CELG ) said late Friday the U.S. Federal Trade Commission cleared their planned merger. The FTC decision clears the path for Bristol-Myers to wrap its $74 billion Celgene merger on Wednesday, t
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Morningstar unveils 10 cheap stocks with big moats [Yahoo! Finance]Yahoo! Finance
- Cramer's Lightning Round: Leidos is a winner [CNBC]CNBC
- United States Frontotemporal Dementia Market to Experience Steady Growth Through 2028 [Yahoo! Finance]Yahoo! Finance
- Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Pfizer, Astellas first-line bladder cancer therapy accepted for review in China [Seeking Alpha]Seeking Alpha
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 3/28/24 - Form DEFA14A
- 3/28/24 - Form DEFA14A
- 3/18/24 - Form 4
- PFE's page on the SEC website